Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases.

MLA

Tokito, Takaaki, et al. “Efficacy of Bevacizumab-Containing Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer with Bone Metastases.” Cancer Chemotherapy & Pharmacology, vol. 71, no. 6, June 2013, pp. 1493–98. EBSCOhost, https://doi.org/10.1007/s00280-013-2148-3.

APA

Tokito, T., Shukuya, T., Akamatsu, H., Taira, T., Ono, A., Kenmotsu, H., Naito, T., Murakami, H., Takahashi, T., Endo, M., & Yamamoto, N. (2013). Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases. Cancer Chemotherapy & Pharmacology, 71(6), 1493–1498. https://doi.org/10.1007/s00280-013-2148-3

Chicago

Tokito, Takaaki, Takehito Shukuya, Hiroaki Akamatsu, Tetsuhiko Taira, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, et al. 2013. “Efficacy of Bevacizumab-Containing Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer with Bone Metastases.” Cancer Chemotherapy & Pharmacology 71 (6): 1493–98. doi:10.1007/s00280-013-2148-3.